(Q38504324)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

review article

6 references

31 July 2020

14 September 2020

1 February 2021

19 July 2021

6 October 2022

Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

31 July 2020

1 reference

14 September 2020

1 reference

1 February 2021

anti-inflammatory agent

1 reference

19 July 2021

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Kislay Roy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

Jagat R Kanwar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Yogesh Patel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Shu-Feng Zhou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Manju Rawat Singh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Deependra Singh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Muhammad Nasir

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Rakesh Sehgal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Alka Sehgal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Ram Sarup Singh

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Rupinder K Kanwar

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

26 May 2015

6 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

31 July 2020

14 September 2020

1 February 2021

19 July 2021

6 October 2022

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

31 July 2020

14 September 2020

1 February 2021

19 July 2021

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

9703-9731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

15 February 2020

copyright license

5 references

31 July 2020

14 September 2020

1 February 2021

19 July 2021

6 October 2022

0 references

Bioactive peptides derived from milk proteins and their health beneficial potentials: an update

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Molecular structure, binding properties and dynamics of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute leukaemia

21 January 2018

2 references

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

21 January 2018

12 December 2020

Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Biological role of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin: structure, function and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Nanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: the role of cell surface sulphated molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Cancer prevention by natural compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Mucosal defense of the outer eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Antimicrobial components of vaginal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin, an iron-binding protein in neutrophilic leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

PEGylated lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Characterization of goat milk lactoferrin N-glycans and comparison with the N-glycomes of human and bovine milk

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Iron and chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 A resolution and structural basis of its dual role

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Identification of the bactericidal domain of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Bovine lactoferrin induces cell cycle arrest and inhibits mTOR signaling in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Oral lactoferrin treatment of experimental oral candidiasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Safety and efficacy of lactoferrin versus ferrous sulphate in curing iron deficiency and iron deficiency anaemia in hereditary thrombophilia pregnant women: an interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin delivery systems: approaches for its more effective use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin-induced reduction of vanB vancomycin resistance in enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

The host-protein-independent iron uptake by Tritrichomonas foetus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin—a multifunctional protein with antimicrobial properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Bovine lactoferrin improves bone status of ovariectomized mice via immune function modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin deficiency promotes colitis-associated colorectal dysplasia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Immune evasion by staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Killing of gram-negative bacteria by lactoferrin and lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin: a modulator of immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Mammalian lactoferrin receptors: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Immunomodulatory effects of lactoferrin on antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Sialic acid-containing milk proteins show differential immunomodulatory activities independent of sialic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Detection of bovine lactoferrin binding protein on Jurkat human lymphoblastic T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Identification of lactoferrin peptides generated by digestion with human gastrointestinal enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Current advances in research and clinical applications of PLGA-based nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Role of nanotechnology in targeted drug delivery and imaging: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Nanocarriers for nuclear imaging and radiotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Designing multifunctional quantum dots for bioimaging, detection, and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Nanoparticle-based theranostic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Antiangiogenic anticancer strategy based on nanoparticulate systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Chitosan surface-modified hydroxycamptothecin loaded nanoparticles with enhanced transport across Caco-2 cell monolayer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

The effect of bovine milk lactoferrin on human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Liposomal nanomedicine for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Cellular delivery of PEGylated PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Multiple presentation of Scfv800E6 on silica nanospheres enhances targeting efficiency toward HER-2 receptor in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Cancer prevention by bovine lactoferrin: from animal studies to human trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin-Conjugated Biodegradable Polymersome Holding Doxorubicin and Tetrandrine for Chemotherapy of Glioma Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Enzymatically cross-linked bovine lactoferrin as injectable hydrogel for cell delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Twenty-five years of research on bovine lactoferrin applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Fabrication and Morphological Characterization of Biopolymer Particles Formed by Electrostatic Complexation of Heat Treated Lactoferrin and Anionic Polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Formation of protein nanoparticles by controlled heat treatment of lactoferrin: Factors affecting particle characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Adsorption and spectroscopic characterization of lactoferrin on hydroxyapatite nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20069703

Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12

21 January 2018

1 reference

12 December 2020

Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice

1 reference

12 December 2020

Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin

1 reference

12 December 2020

Elucidation of the antistaphylococcal action of lactoferrin and lysozyme

1 reference

12 December 2020

Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cells

1 reference

12 December 2020

Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism

1 reference

12 December 2020

Regulation of epidermal Langerhans cell migration by lactoferrin

1 reference

12 December 2020

Oxidative stress and vascular damage in hypertension

1 reference

12 December 2020

Gastric digestion of bovine lactoferrin in vivo in adults

1 reference

12 December 2020

Lactoferrin regulates the immune responses in post-surgical patients

1 reference

12 December 2020

[Recent advances of basic research and clinical application of lactoferrin as an antiviral reagent against chronic hepatitis C]

1 reference

12 December 2020

Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients

1 reference

12 December 2020

Expression of lactoferrin on neutrophil granulocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis

1 reference

12 December 2020

Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.

1 reference

12 December 2020

Supplementation of an adapted formula with bovine lactoferrin. 2. Effects on serum iron, ferritin and zinc levels

1 reference

12 December 2020

The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice

1 reference

12 December 2020

Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin

1 reference

12 December 2020

Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin

1 reference

12 December 2020

Staphylococcal superantigens: do they play a role in sepsis?

1 reference

12 December 2020

Immunostimulatory activity of lactotransferrin and maturation of CD4− CD8− murine thymocytes

1 reference

12 December 2020

A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants

1 reference

12 December 2020

Lactoferrin modulation of antigen-presenting-cell response to BCG infection

1 reference

12 December 2020

Influence of Lactoferrin on the Function of Human Polymorphonuclear Leukocytes and Monocytes

1 reference

12 December 2020

Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males

1 reference

12 December 2020

Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction.

1 reference

12 December 2020

[The influences of camel milk on the immune response of chronic hepatitis B patients].

1 reference

12 December 2020

Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems

1 reference

12 December 2020

Beneficial effect of camel milk in diabetic nephropathy.

1 reference

12 December 2020

Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women

1 reference

12 December 2020

Antioxidant enzyme activities of iron-saturated bovine lactoferrin (Fe-bLf) in human gut epithelial cells under oxidative stress

1 reference

12 December 2020

Bovine lactoferrin induces interleukin-11 production in a hepatitis mouse model and human intestinal myofibroblasts

1 reference

12 December 2020

The surface charge of Toxoplasma gondii: a cytochemical and electrophoretic study

1 reference

12 December 2020

The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis

1 reference

12 December 2020

Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis

1 reference

12 December 2020

Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo

1 reference

12 December 2020

Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin

1 reference

12 December 2020

Human lactoferrin stimulates thymidine incorporation into DNA of rat crypt cells

1 reference

12 December 2020

Lactoferrin and transferrin: a comparative study.

1 reference

12 December 2020

Iron-binding Proteins in Milk and Resistance to Escherichia coli Infection in Infants

1 reference

12 December 2020

Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Detection by immunoperoxidase staining for lactoferrin and cytochemical electron microscopy

1 reference

12 December 2020

Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms

1 reference

12 December 2020

Distribution of lactoferrin in human salivary glands

1 reference

12 December 2020

Giardicidal activity of lactoferrin and N-terminal peptides

1 reference

12 December 2020

Lactoferrin and the inflammatory response

1 reference

12 December 2020

Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer

1 reference

12 December 2020

Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice.

1 reference

12 December 2020

Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo

1 reference

12 December 2020

Functional lactoferrin receptors on activated human lymphocytes

1 reference

12 December 2020

Activation of macrophages by lactoferrin: secretion of TNF-alpha, IL-8 and NO

1 reference

12 December 2020

Activated human gamma delta T lymphocytes express functional lactoferrin receptors

1 reference

12 December 2020

Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system

1 reference

12 December 2020

10.3390/MOLECULES20069703

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

release_nkbiuxtvybetto2wdmnrbowfzm

15 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nkbiuxtvybetto2wdmnrbowfzm

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

26016555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26016555%20AND%20SRC:MED&resulttype=core&format=json